13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001009258
申报总市值
US$95.9亿
US$95.9亿
82 檔
33.4%
根据最新整理的 13F 季度数据集，Deerfield Management Company, L.p. 于 Q1 2026 结束时的管理资产规模为 US$95.9亿。该机构在本季度申报了 82 档美股持仓，呈现出该时期的主要投资地图。
在 Q1 2026，Deerfield Management Company, L.p. 展现出较为审慎的避险与获利了结姿态。本季共减仓 9 个仓位并完全清仓 80 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Deerfield Management Company, L.p. 的前 5 大核心持股（包含 NUVL, BKD 3.5 10-15-29, COGT 等）合计占整体申报市值的 33.4%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NUVL | Nuvalent Inc-a | 股票-其他 | 20.85% | +1.37% | — | |
| 2 | BKD 3.5 10-15-29债券 | Brookdale Senior Living | 债券 | 5.96% | +0.15% | — | |
| 3 | COGT | Cogent Biosciences Inc | 股票-其他 | 4.11% | -2.09% | — | |
| 4 | PRAX | Praxis Precision Medicines I | 股票-其他 | 3.66% | -0.30% | +6.64% | |
| 5 | VTRS | Viatris Inc | 股票-医疗保健 | 3.22% | +0.13% | — | |
| 6 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 3.20% | -0.62% | +7.28% | |
| 7 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 2.64% | +2.03% | -20.65% | |
| 8 | MIRM 4 05-01-29债券 | Mirum Pharmaceuticals | 债券 | 2.47% | -2.47% | EXIT | |
| 9 | ARWR 0 01-15-32债券 | Arrowhead Research CORP | 债券 | 2.44% | +0.07% | — | |
| 10 | CELC | Celcuity Inc | 股票-其他 | 2.31% | -0.73% | — | |
| 11 | CNC | Centene CORP | 股票-医疗保健 | 2.29% | +0.99% | -8.23% | |
| 12 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 1.89% | -0.76% | +16.34% | |
| 13 | BKD | Brookdale Senior Living Inc | 股票-其他 | 1.88% | +0.07% | — | |
| 14 | VERA | Vera Therapeutics Inc | 股票-其他 | 1.77% | -0.02% | -8.32% | |
| 15 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 1.75% | -0.11% | — | |
| 16 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 1.69% | -0.12% | +4.86% | |
| 17 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 1.64% | -1.04% | +79.51% | |
| 18 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 1.64% | +0.81% | +29.60% | |
| 19 | AHCO | Adapthealth CORP | 股票-其他 | 1.61% | -0.36% | — | |
| 20 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 1.61% | -0.10% | +2.40% | |
| 21 | ACHC | Acadia Healthcare Co Inc | 股票-其他 | 1.25% | +0.14% | — | |
| 22 | ARWR | Arrowhead Pharmaceuticals In | 股票-医疗保健 | 1.16% | +0.02% | -14.17% | |
| 23 | CPRX | Catalyst Pharmaceuticals Inc | 股票-医疗保健 | 1.15% | -1.15% | EXIT | |
| 24 | INDV | Indivior Pharmaceuticals Inc | 股票-其他 | 1.11% | -0.40% | — | |
| 25 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 1.11% | -0.09% | +198.09% | |
| 26 | IONS 1.75 06-15-28债券 | Ionis Pharmaceuticals In | 债券 | 1.07% | -0.10% | — | |
| 27 | PHVS | Pharvaris N.V. | 股票-其他 | 1.04% | +0.18% | — | |
| 28 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 1.04% | -0.18% | — | |
| 29 | TNGX | Tango Therapeutics Inc | 股票-其他 | 1.02% | +0.35% | +42.65% | |
| 30 | ALHC 4.25 11-15-29债券 | Alignment Healthcare | 债券 | 1.01% | +0.07% | — | |
| 31 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 1.01% | +0.13% | — | |
| 32 | PFE | Pfizer Inc | 股票-医疗保健 | 1.01% | -0.25% | — | |
| 33 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 0.95% | -0.95% | EXIT | |
| 34 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 0.94% | -0.94% | EXIT | |
| 35 | SVRA | Savara Inc | 股票-其他 | 0.87% | — | — | |
| 36 | ZBIO 2.5 04-01-32债券 | Zenas Biopharma Inc | 债券 | 0.79% | +0.05% | — | |
| 37 | EHABUSD | Enhabit Inc | 股票-其他 | 0.79% | -0.79% | EXIT | |
| 38 | NEO 0.25 01-15-28债券 | Neogenomics Inc | 债券 | 0.79% | -0.66% | — | |
| 39 | GMAB | Genmab A/s -sp Adr | 股票-其他 | 0.78% | +1.19% | — | |
| 40 | BIO | Bio-rad Laboratories-a | 股票-医疗保健 | 0.74% | -0.05% | — | |
| 41 | LNTH | Lantheus Holdings Inc | 股票-医疗保健 | 0.74% | +0.13% | — | |
| 42 | SPRY | Ars Pharmaceuticals Inc | 股票-其他 | 0.71% | -0.08% | — | |
| 43 | STOK | Stoke Therapeutics Inc | 股票-其他 | 0.70% | -0.08% | — | |
| 44 | NVST | Envista Holdings CORP | 股票-医疗保健 | 0.66% | -0.05% | -3.09% | |
| 45 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 0.60% | +0.46% | -28.94% | |
| 46 | BLTE | Belite Bio Inc - Adr | 股票-其他 | 0.57% | — | +30.02% | |
| 47 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 0.57% | +0.23% | — | |
| 48 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 0.55% | -0.55% | EXIT | |
| 49 | CERT | Certara Inc | 股票-其他 | 0.53% | -0.02% | — | |
| 50 | BBOT | Bridgebio Oncology Therapeut | 股票-其他 | 0.52% | -0.13% | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | XENE | Xenon Pharmaceuticals Inc | +0.8% | +198.09% | 加仓 |
| 2 | TNGX | Tango Therapeutics Inc | +0.7% | +42.65% | 加仓 |
| 3 | UTHR | United Therapeutics CORP | +0.6% | +7.28% | 加仓 |
| 4 | BKD 3.5 10-15-29债券 | Brookdale Senior Living | +0.5% | — | 不变 |
| 5 | DAWNGBX | Day One Biopharmaceuticals I | +0.5% | — | 不变 |
| 6 | ACHC | Acadia Healthcare Co Inc | +0.4% | — | 不变 |
| 7 | LRMR | Larimar Therapeutics Inc | +0.4% | +16.34% | 加仓 |
| 8 | BKD | Brookdale Senior Living Inc | +0.3% | — | 不变 |
| 9 | PRAX | Praxis Precision Medicines I | +0.3% | +6.64% | 加仓 |
| 10 | BCRX | Biocryst Pharmaceuticals Inc | +0.3% | +4.86% | 加仓 |
| 11 | EHABUSD | Enhabit Inc | +0.2% | — | 不变 |
| 12 | MIRM 4 05-01-29债券 | Mirum Pharmaceuticals | +0.2% | — | 不变 |
| 13 | AHCO | Adapthealth CORP | +0.2% | — | 不变 |
| 14 | CELC | Celcuity Inc | +0.1% | — | 不变 |
| 15 | BLTE | Belite Bio Inc - Adr | +0.1% | +30.02% | 加仓 |
| 16 | MNPR | Monopar Therapeutics Inc | +0.1% | +89.82% | 加仓 |
| 17 | LNTH | Lantheus Holdings Inc | 0% | — | 不变 |
| 18 | NVST | Envista Holdings CORP | 0% | -3.09% | 减仓 |
| 19 | COGT | Cogent Biosciences Inc | 0% | — | 不变 |
| 20 | VTRS | Viatris Inc | 0% | — | 不变 |
| 21 | CGEM | Cullinan Therapeutics Inc | 0% | — | 不变 |
| 22 | ALEC | Alector Inc | 0% | — | 不变 |
| 23 | PHGE | Biomx Inc | 0% | +0.00% | 加仓 |
| 24 | FHTX | Foghorn Therapeutics Inc | — | +20.42% | 加仓 |
| 25 | ANNX | Annexon Inc | — | — | 不变 |
| 26 | TOIIW | Oncology Institute Inc Cw-22 | — | — | 不变 |
| 27 | HUM | Humana Inc | — | — | 不变 |
| 28 | EW | Edwards Lifesciences CORP | — | — | 不变 |
| 29 | QSIAW | Quantum-si Inc -cw27 | — | — | 不变 |
| 30 | MYGN | Myriad Genetics Inc | — | — | 不变 |
| 31 | SRZNW | Surrozen Inc-cw25 | — | — | 不变 |
| 32 | PMVP | Pmv Pharmaceuticals Inc | — | — | 不变 |
| 33 | LEGN | Legend Biotech Corp-adr | 0% | +29.60% | 加仓 |
| 34 | KYMR | Kymera Therapeutics Inc | 0% | — | 不变 |
| 35 | ✓ | Newamsterdam Pharma Company | 0% | — | 不变 |
| 36 | IRON | Disc Medicine Inc | 0% | +28.53% | 加仓 |
| 37 | TOI | Oncology Institute Inc/the | 0% | — | 不变 |
| 38 | CMPX | Compass Therapeutics Inc | 0% | — | 不变 |
| 39 | IMCR 2.5 02-01-30债券 | Immunocore Holdings | 0% | — | 不变 |
| 40 | NEO 0.25 01-15-28债券 | Neogenomics Inc | 0% | — | 不变 |
| 41 | KYTX | Kyverna Therapeutics Inc | 0% | — | 不变 |
| 42 | STOK | Stoke Therapeutics Inc | 0% | — | 不变 |
| 43 | LIVN 2.5 03-15-29债券 | Livanova PLC | 0% | — | 不变 |
| 44 | TSHA | Taysha Gene Therapies Inc | -0.1% | — | 不变 |
| 45 | SION | Sionna Therapeutics Inc | -0.1% | — | 不变 |
| 46 | ALNY | Alnylam Pharmaceuticals Inc | -0.1% | — | 不变 |
| 47 | PHVS | Pharvaris N.V. | -0.1% | — | 不变 |
| 48 | CDNA | Caredx Inc | -0.1% | — | 不变 |
| 49 | VCYT | Veracyte Inc | -0.1% | — | 不变 |
| 50 | BIO | Bio-rad Laboratories-a | -0.1% | — | 不变 |
根据 SEC 官方 Form 13F 申报备案，Deerfield Management Company, L.p. 在 Q1 2026 季度的美股持仓总市值约为 US$95.9亿，共申报了 82 个公开持股仓位。
在 Q1 2026 季度，Deerfield Management Company, L.p. 按市值排列的前三大核心持股分别为：NUVL (20.9%)、BKD 3.5 10-15-29 (6.0%)、COGT (4.1%)。其中最大持股仓位 NUVL 占据整体投资组合约 20.9% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
ARWR 0 01-15-32
市值: US$2.1亿
本季最大获利了结 / 清仓标的
INDV
前期市值: US$1.2亿
在 Q1 2026 季度中，Deerfield Management Company, L.p. 共进行了 116 项持仓异动，包含新建仓 12 个仓位、加仓 15 个仓位、减仓 9 个仓位以及清仓 80 个仓位。 其中最大新建仓标的为 ARWR 0 01-15-32。 本季清仓仓位包含 INDV。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。